Latest filing published 29 Sept 2026 for Veraxa Biotech AG, €8,646.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +107.1%Entry US$99.49 · Close 22 Oct 2026 US$206.09
- -30.2%Entry US$5.30 · Close at T+365 US$3.70
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Warren Hosseinion: trading record in brief
This profile gathers the share dealings of Warren Hosseinion across 3 companies, led by Astrana Health, Inc., Nutex Health, Inc. and Veraxa Biotech AG. Between 13 June 2008 and 10 September 2026, the trades on record add up to 60 filings.
In open-market terms, that means 5 purchases worth €538.4M on one side and 43 sales worth €9.2M on the other. No amount is published for 1 filing, which the totals therefore leave out. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 4 share grants and 4 option exercises. Since January 2026: 2 purchases and no sales on the market.
The median purchase comes to €15k.
The record was last updated on 29 September 2026 with an open-market purchase (€8,646) in Veraxa Biotech AG. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Warren Hosseinion
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 6,024 shares@ US$1.67100.0% of flowOrdinary SharesSEC:0001829126-26-010557:0Canonical exit: 9 Dec 2026 (T+90)
- 252 shares@ US$94.0723100.0% of flowCommon StockSEC:0001438327-26-000002:0Canonical exit: 17 Jun 2026 (T+90)
- 3,274 shares@ US$86.226.1% of flowCommon StockSEC:0001438327-26-000001:1
- 6,293 shares0Common StockSEC:0001438327-26-000001:0
- 1,072 shares@ US$72.101.8% of flowCommon StockSEC:0001486189-25-000011:1
- 3,776 shares0Common StockSEC:0001486189-25-000011:0
- 141,000 shares0Common StockSEC:0001486189-23-000036:0
- 70,000 shares@ US$2.364.2% of flowCommon StockSEC:0001486189-22-000019:1
- 130,000 shares@ US$2.4640.0% of flowCommon StockSEC:0001486189-22-000019:0
- 150,000 shares@ US$2.8410.8% of flowCommon StockSEC:0001486189-22-000017:1
- 100,000 shares@ US$2.9937.4% of flowCommon StockSEC:0001486189-22-000017:0
- 180,000 shares@ US$2.4811.3% of flowCommon StockSEC:0001486189-22-000016:1
- 100,000 shares@ US$2.797.1% of flowCommon StockSEC:0001486189-22-000016:2
- 70,000 shares@ US$2.56422.5% of flowCommon StockSEC:0001486189-22-000016:0
- 102,888 shares0Common StockSEC:0001486189-22-000013:0
- 894,209 shares@ US$2.04100.0% of flowCommon StockSEC:0001486189-21-000013:0
- 31,746 shares@ US$20,000.00Common StockSEC:0001486189-20-000011:0
- 35,000 shares@ US$16.606.8% of flowCommon StockSEC:0001567619-18-007189:0
- 20,000 shares@ US$17.914.2% of flowCommon StockSEC:0001567619-18-007081:0
- 30,000 shares@ US$17.316.1% of flowCommon StockSEC:0001567619-18-007081:1
- 30,000 shares@ US$16.215.7% of flowCommon StockSEC:0001567619-18-006971:0
- 20,000 shares@ US$17.074.0% of flowCommon StockSEC:0001567619-18-006971:1
- 20,000 shares@ US$18.974.4% of flowCommon StockSEC:0001567619-18-006863:0
- 20,000 shares@ US$17.584.1% of flowCommon StockSEC:0001567619-18-006863:1
- 15,000 shares@ US$16.032.7% of flowCommon StockSEC:0001567619-18-002000:0
25 of 58 declarations
